Wamika Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.66 M
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.80 M
- Revenue Growth -6.43%
- Profit Growth -1.16%
- Ebitda -2.81%
- Net Worth 7.37%
- Total Assets -9.46%
About Wamika Pharmaceuticals
Wamika Pharmaceuticals Pvt. Ltd. (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2001 and has a history of 23 years and eight months. Its registered office is in Na, Haryana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.66 M.
The company currently has active open charges totaling ₹7.80 M.
Naveen Garg and Parveen Garg serve as directors at the Company.
Company Details
- Location Na, Haryana
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233HR2001PTC034685
-
Company No.
034685
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2001
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Wamika Pharmaceuticals Pvt. Ltd. offer?
Wamika Pharmaceuticals Pvt. Ltd. offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Antibiotic Tablets & Capsules, Cefuroxime Axetil Tablets, Antiallergic API, Cyproheptadine HCL API, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Roxithromycin Tablets, Pharmaceutical Tablets.
Who are the key members and board of directors at Wamika Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Garg
|
Director | 23-May-2001 | Current |
|
Parveen Garg
|
Director | 23-May-2001 | Current |
Financial Performance of Wamika Pharmaceuticals.
Wamika Pharmaceuticals Pvt. Ltd., for the financial year ended 2023, experienced Minor drop in revenue, with a 6.43% decrease. The company also saw a slight decrease in profitability, with a 1.16% decrease in profit. The company's net worth moved up by a moderate rise of 7.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wamika Pharmaceuticals?
In 2023, Wamika Pharmaceuticals had a public holding of 72.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.80 M
₹0
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 0.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2011 | Oriental Bank Of Commerce | ₹7.80 M | Open |
How Many Employees Work at Wamika Pharmaceuticals?
Unlock and access historical data on people associated with Wamika Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wamika Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wamika Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.